HHS Announces $6 Million in Grant Funding for Reproductive Health

Oct. 5, 2022
HHS, through the Office of Population Affairs, announced more than $6 million for Title X Family Planning Research grants, Research-to Practice Center grants, and Teenage Pregnancy Evaluation and Research grants

On Oct. 4, the U.S. Department of Health and Human Services (HHS), through the Office of Population Affairs (OPA), announced via a press release more than $6 million for Title X Family Planning Research grants, Research-to-Practice Center grants, and Teenage Pregnancy Prevention Evaluation and Research grants. These grants are part of its work to safeguard and increase access to reproductive healthcare and the funding is meant to go toward service delivery, promoting health behaviors, and reducing health disparities. HHS’ OPA aims to advance best practices for health in family planning and preventative care.

The release says that “Title X Family Planning Research grants aim to conduct research or analyses to generate information that will improve the delivery of family planning services and expand equitable access to quality sexual and reproductive health services offered under Title X of the Public Health Service Act.”

The Title X Family Planning Research grantees include:

The release notes that “OPA’s Teenage Pregnancy Prevention Research Grant projects will explore new questions in teen pregnancy prevention and adolescent sexual and reproductive health to improve the efficiency, effectiveness, and quality of these programs for adolescents or young adults, and/or reduce existing disparities. Funded grantees will conduct research or analyses to generate information that will 1) identify factors that improve the quality, access, and equity of teen pregnancy prevention programs for adolescents or young adults, or that reduce existing disparities, 2) identify and/or validate core program components or “active ingredients” essential for teen pregnancy prevention programs and practices to produce the desired outcomes; and 3) scale and conduct testing of emerging adolescent sexual health innovations in order to generate early data and prepare for future rigorous impact evaluation.”

The Teenage Pregnancy Prevention Evaluation and Research grantees include:

“OPA’s Research-to-Practice Center Grants projects will synthesize and translate existing research into practice to improve adolescent health and ultimately help reduce teen pregnancy,” the release comments. “Projects will focus on expanding the delivery of trauma-informed and inclusive practices in adolescent sexual and reproductive health programming and care and bringing adolescent sexual and reproductive health research to youth-serving professionals.”

Research-to-Practice Center grantees include:

ADM Rachel L. Levine, assistant secretary for health was quoted in the release saying that "These new research grants will provide insights that will help our community partners provide essential, client-centered reproductive health services.”

Additionally, the press release outlines the actions that HHS has taken to ensure access to reproductive healthcare following Dobbs v. Jackson Women’s Health Organization Supreme Court decision including protecting emergency medical care, protecting information on health and rights for patients and providers, protecting patient privacy, and protecting access to birth control.

Sponsored Recommendations

Care Access Made Easy: A Guide to Digital Self Service

Embracing digital transformation in healthcare is crucial, and there is no one-size-fits-all strategy. Consider adopting a crawl, walk, run approach to digital projects, enabling...

Powering a Digital Front Door with a Comprehensive Provider Directory

Learn how Geisinger improved provider data accuracy, SEO, and patient acquisition with a comprehensive provider directory.

Data-driven, physician-focused approach to CDI improvement

Organizational profile Sisters of Charity of Leavenworth (SCL) Health* has been providing care since it originated in the 1600s in France as the Daughters of Charity. These religious...

Luminis Health improved quality and financial outcomes with advanced CDI technology and consulting from 3M

In the beginning, there were challengesBefore partnering with 3M Health Information Systems (HIS), Luminis Health’s clinical documentation integrity (CDI) program faced ...

According to an Oct. 10 press release, a report by the World Health Organization (WHO) finds that vaccines against 24 pathogens could reduce the number of antibiotics needed by 22% or 2.5 billion defined daily doses globally every year, supporting worldwide efforts to address antimicrobial resistance (AMR). While some of these vaccines are already available but underused, others would need to be developed and brought to the market as soon as possible. AMR occurs when bacteria, viruses, fungi, and parasites no longer respond to antimicrobial medicines, making people sicker and increasing the risk of illness, death and the spread of infections that are difficult to treat. AMR is driven largely by the misuse and overuse of antimicrobials, yet, at the same time, many people around the world do not have access to essential antimicrobials. Each year, nearly 5 million deaths are associated with AMR globally. Vaccines are an essential part of the response to reduce AMR as they prevent infections, reduce the use and overuse of antimicrobials, and slow the emergence and spread of drug-resistant pathogens. The new report expands on a WHO study published in BMJ Global Health last year. It estimates that vaccines already in use against pneumococcus pneumonia, Haemophilus influenzae type B (Hib, a bacteria causing pneumonia and meningitis) and typhoid could avert up to 106 000 of the deaths associated with AMR each year. An additional 543 000 deaths associated with AMR could be averted annually when new vaccines for tuberculosis (TB) and Klebsiella pneumoniae, are developed and rolled out globally. While new TB vaccines are in clinical trials, one against Klebsiella pneumoniae is in early stage of development.
dreamstime_xxl_210174616_1